- Home
- HCM vs DX Comparison
HCM vs DX Comparison
Compare HCM & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | DX |
|---|---|---|
| Founded | 2000 | 1987 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HCM | DX |
|---|---|---|
| Price | $14.98 | $14.01 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $13.75 | ★ $13.83 |
| AVG Volume (30 Days) | 44.6K | ★ 5.6M |
| Earning Date | 08-07-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 14.53% |
| EPS Growth | N/A | ★ 35.65 |
| EPS | 0.53 | ★ 1.66 |
| Revenue | ★ $602,197,000.00 | $230,447,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.54 | $134.14 |
| P/E Ratio | ★ $5.58 | $8.46 |
| Revenue Growth | N/A | ★ 87.09 |
| 52 Week Low | $11.51 | $10.79 |
| 52 Week High | $19.50 | $14.52 |
Technical Indicators
Market Signals| Indicator | HCM | DX |
|---|---|---|
| Relative Strength Index (RSI) | 64.80 | 57.43 |
| Support Level | $14.63 | $13.90 |
| Resistance Level | $15.00 | $14.27 |
| Average True Range (ATR) | 0.40 | 0.21 |
| MACD | 0.22 | -0.00 |
| Stochastic Oscillator | 83.57 | 53.32 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.